Express News | Colgate-Palmolive Co : Piper Sandler Initiates Coverage With Overweight Rating; Target Price $121
Piper Sandler Initiates Colgate-Palmolive(CL.US) With Buy Rating, Announces Target Price $121
Piper Sandler analyst Korinne Wolfmeyer initiates coverage on $Colgate-Palmolive(CL.US)$ with a buy rating, and sets the target price at $121.According to TipRanks data, the analyst has a success
Overweight Quality Stocks With Positive EPS Revision - MS
Colgate-Palmolive Company and 1,000 Dreams Fund Partner to Launch Colgate-Palmolive Scholars Program for Women in Healthcare
United States Cosmetics Market Report and Company Analysis 2024-2032 Featuring Coty, Procter & Gamble, Estee Lauder, Colgate-Palmolive, Johnson & Johnson, Revlon, and Mary Kay - ResearchAndMarkets.com
Citigroup Adjusts Price Target on Colgate-Palmolive to $120 From $115, Maintains Buy Rating
Is Colgate-Palmolive Company (CL) The Best Household and Personal Care Stocks to Buy Now?
Weekend Reading | The 'dispersion' gene of colgate-palmolive and its ups and downs
As the former big brother, colgate-palmolive, who was once overtaken by procter & gamble in the first place in the soap and toothpaste market, how can they make a comeback?
Colgate-Palmolive's (NYSE:CL) Earnings Growth Rate Lags the 9.6% CAGR Delivered to Shareholders
Jim Carter on Colgate-Palmolive Company (CL): 'A Surprising Downgrade at Wells Fargo'
Unmissable investment strategy! The Federal Reserve officially enters a new era of interest rate cuts, these 6 industries have the most profitable potential.
Prepare yourself for the interest rate cut cycle.
Colgate-Palmolive Company (CL) JPMorgan 15th Annual U.S. All Stars Conference (Transcript)
Nestle, Colgate-Palmolive, Alphabet: 3 Stocks In Focus
Colgate-Palmolive Price Target Announced at $100.00/Share by Wells Fargo
Colgate-Palmolive Analyst Ratings
Colgate-Palmolive Downgraded by Wells Fargo as Growth Normalization Looms
Colgate-Palmolive Dips After Outlier Bear Call From Wells Fargo
Wells Fargo Downgrades Colgate-Palmolive(CL.US) to Sell Rating, Maintains Target Price $100
Wells Fargo analyst Christopher Carey downgrades $Colgate-Palmolive(CL.US)$ to a sell rating, and maintains the target price at $100.According to TipRanks data, the analyst has a success rate of 54.6%
Wells Fargo Downgrades Colgate-Palmolive to Underweight From Equalweight
Returns At Colgate-Palmolive (NYSE:CL) Appear To Be Weighed Down